Unaudited Consolidated Balance Sheets - USD ($) $ in Millions		Mar. 31, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents		$ 951	$ 962
Trade receivables - third party and affiliates		1,240	1,121
Non-trade receivables, net		640	493
Inventories		2,309	2,284
Other assets		278	285
Total current assets		5,418	5,145
Investments in affiliates		1,220	1,217
Property, plant and equipment (net of accumulated depreciation - 2025: $4,755; 2024: $4,562)		5,259	5,273
Operating lease right-of-use assets		379	388
Deferred income taxes		1,295	1,251
Other assets		543	555
Goodwill	[1]	5,413	5,387
Intangible assets, net		3,670	3,641
Total assets		23,197	22,857
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates		406	1,501
Trade payables - third party and affiliates		1,314	1,228
Other liabilities		997	1,120
Income taxes payable		80	4
Total current liabilities		2,797	3,853
Long-term debt, net of unamortized deferred financing costs		12,378	11,078
Deferred income taxes		924	933
Uncertain tax positions		291	286
Benefit obligations		396	396
Operating lease liabilities		284	294
Other liabilities		512	408
Commitments and Contingencies
Shareholders' Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2025 and 2024: 0 issued and outstanding)		0	0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2025: 170,903,043 issued and 109,403,403 outstanding; 2024: 170,827,196 issued and 109,327,556 outstanding)		0	0
Treasury stock, at cost (2025: 61,499,640 shares; 2024: 61,499,640 shares)		(5,486)	(5,486)
Additional paid-in capital		413	409
Retained earnings		11,076	11,100
Accumulated other comprehensive income (loss), net		(817)	(848)
Total Celanese Corporation shareholders' equity		5,186	5,175
Noncontrolling interests		429	434
Total equity		5,615	5,609
Total liabilities and equity		$ 23,197	$ 22,857

[1] (1)Includes accumulated impairment losses of $1.5 billion in the Engineered Materials segment as of March 31, 2025 and December 31, 2024.